LIA
RGNX icon

LS Investment Advisors’s Regenxbio RGNX Stock Holding History

LS Investment Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,436
Closed -$90K – 1300
2020
Q2 		$90K Buy
2,436
+108
+5% +$4.03K 0.01% 1018
2020
Q1 		$75K Hold
2,328
– – 0.01% 999
2019
Q4 		$95K Hold
2,328
– – 0.01% 1127
2019
Q3 		$83K Hold
2,328
– – ﹤0.01% 1133
2019
Q2 		$120K Hold
2,328
– – 0.01% 1014
2019
Q1 		$133K Buy
2,328
+68
+3% +$3.37K 0.01% 973
2018
Q4 		$95K Buy
2,260
+874
+63% +$51.3K 0.01% 1078
2018
Q3 		$105K Buy
1,386
+134
+11% +$9.65K 0.01% 1115
2018
Q2 		$90K Buy
+1,252
New +$59.8K 0.01% 1167

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

LS Investment Advisors's RGNX Position: Q3 2020 in Review

LS Investment Advisors sold out of Regenxbio (RGNX) in Q3 2020, closing a stake of 2,436 shares — an estimated $90K sold.

LS Investment Advisors first reported a position in RGNX in Q2 2018 and held it in 9 quarters. The position peaked at $133K in Q1 2019. 166 funds tracked by Wall St. Rank hold RGNX as of Q3 2020.

  • LS Investment Advisors reported no remaining Regenxbio position as of Q3 2020 after selling out during the quarter.
  • LS Investment Advisors sold 2,436 Regenxbio shares in Q3 2020, an estimated $90K.
  • LS Investment Advisors first reported a position in Regenxbio in Q2 2018 and held it in 9 quarters.
  • LS Investment Advisors's Regenxbio position peaked at $133K in Q1 2019.
  • 166 funds tracked by Wall St. Rank held Regenxbio as of Q3 2020.

Based on LS Investment Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.